HERBALIFE LTD. Deferred Tax Assets, Valuation Allowance
HERBALIFE LTD. (HLF) had Deferred Tax Assets, Valuation Allowance of $336.80 million as of 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-02-18
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $336.80M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $404.20M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $375.50M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $436.60M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2025-12-31 | $336.80M 10-K · filed 2026-02-18 | |
| 2024-12-31 | $404.20M 10-K · filed 2026-02-18 | |
| 2023-12-31 | $375.50M 10-K · filed 2025-02-19 | |
| 2022-12-31 | $436.60M 10-K · filed 2024-02-14 | |
| 2021-12-31 | $411.90M 10-K · filed 2023-02-14 | |
| 2020-12-31 | $390.80M 10-K · filed 2022-02-23 | |
| 2019-12-31 | $330.30M 10-K · filed 2021-02-17 | |
| 2018-12-31 | $319.10M 10-K · filed 2020-02-18 | $382.90M 10-K · filed 2019-02-19 |
| 2017-12-31 | $299.40M 10-K · filed 2019-02-19 | |
| 2016-12-31 | $115.40M 10-K · filed 2018-02-22 | |
| 2015-12-31 | $121.30M 10-K · filed 2017-02-23 | |
| 2014-12-31 | $330.00M 10-K · filed 2016-02-25 | |
| 2013-12-31 | $247.60M 10-K · filed 2015-02-26 | |
| 2012-12-31 | $209.30M 10-K · filed 2014-02-18 | |
| 2011-12-31 | $168.10M 10-K/A · filed 2013-12-16 | $208.30M 10-K · filed 2012-02-21 |
| 2010-12-31 | $124.20M 10-K/A · filed 2012-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |